跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
傳染性疾病及訊息研究中心
國立成功大學
電話
886-6-2757575 Ext.75891
電子郵件
[email protected]
網站
https://cidsr.web2.ncku.edu.tw/
Postal address
在地圖上顯示
概覽
指紋
網路
概要
(1)
專案
(2)
研究成果
(88)
指紋
查看啟用 傳染性疾病及訊息研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tubulin
62%
DNA Topoisomerase (ATP Hydrolysing)
53%
IC50
48%
Antiproliferative Activity
40%
Colchicine
38%
Multidrug Resistance Associated Protein
34%
Camptothecin
32%
Aurora Kinase Inhibitor
32%
Methylated DNA Protein Cysteine Methyltransferase
32%
Transcription Factor Nrf2
32%
Gemcitabine
24%
Aurora Kinase
24%
Messenger RNA
22%
Sulfonamide
20%
DNA Methyltransferase
18%
Anticarcinogen
18%
Chemotherapy
18%
Indole
18%
Ataxia Telangiectasia
18%
Antioxidant
17%
Nitrosourea
17%
Neoplasm
16%
Microtubule Inhibitors
16%
Combretastatin A4
16%
Glutathione
16%
Drug Resistance
16%
Oxaliplatin
16%
Fluorouracil
16%
Pancreas Cancer
16%
Folinic Acid
16%
Structure Activity Relationship
16%
Pharmacokinetic
16%
DNA Topoisomerase
16%
Mouse Model
16%
Chemoradiation Therapy
16%
Toluidine Derivative
16%
Peripheral T Cell Lymphoma
16%
8 (6 Methoxy 3 Pyridinyl) 3 Methyl 1 [4 (1 Piperazinyl) 3 (Trifluoromethyl)phenyl] 1h imidazo[4,5 C]quinolin 2(3h) One
16%
Cancer Pain
16%
Isonicotinamide
16%
Ketamine
16%
Somatomedin Binding Protein 3
16%
Intrathecal
16%
Head and Neck Squamous Cell Carcinoma
16%
Ubiquitin Conjugating Enzyme E2
16%
Salvia Miltiorrhiza
16%
Morphine
16%
RNA Binding Protein
16%
Chromosome Translocation
16%
Cell Adhesion Proteins
16%
Coix
16%
Benzylamine
16%
ELAV Like Protein 1
16%
Cytotoxicity
16%
Protein Binding
16%
PPAR Agonist
16%
Irinotecan Sucrosofate
16%
Menadione
16%
Tumor Thrombus
16%
Bile Duct Carcinoma
16%
Glucose 6 Phosphate Dehydrogenase
16%
Coumarin Derivative
16%
Oxime
16%
Terpenoid
16%
Hypoxia Inducible Factor 1
16%
Blastocystis hominis
16%
Benzenesulfonamide
16%
Tamoxifen
16%
Carcinomatous Peritonitis
16%
Afferent Loop Syndrome
16%
CD44v Antigen
16%
Head and Neck Cancer
16%
Transketolase
16%
Benzamide Derivative
16%
Cytoprotective Agent
14%
Binding Site
14%
Stomach Adenocarcinoma
13%
Epitope
13%
Congocidine
12%
Congocidine Derivative
12%
Western Blot
12%
Albumin
12%
Tumor Growth
11%
Carcinogenesis
11%
Etoposide
11%
Hexane
10%
Pancreas Adenocarcinoma
10%
Cell Protein
9%
Antitumor Activity
8%
Caspase 9
8%
Cyclin B1
8%
Antiinfective Agent
8%
Nude Mouse
8%
Murine Leukemia
8%
Multidrug Resistance
8%
R-Factor
8%
Cytochrome C
8%
Pibenzimol
8%
Caspase 3
8%
Keyphrases
Novel Class
40%
IC50 Value
36%
Tubulin
36%
Tubulin Polymerization Inhibitors
32%
8-dione
32%
Antitumor Agents
32%
Antitubulin Agents
24%
Colchicine
24%
Antiproliferative Activity
24%
Indoline
21%
Colchicine Binding Site
20%
Microtubules
20%
Multidrug Resistance Protein
18%
Cancer Cell Lines
16%
Cancer Cells
16%
Benzenesulfonamide
16%
Sulfonamides
16%
Antimitotic Activity
16%
Antimitotic Agents
16%
Antitumoral Activity
16%
Structure-activity Relationship
16%
Combretastatin A4 Phosphate (CA4P)
16%
Calocedrus Macrolepis
16%
Bark
16%
Camptothecin Resistance
16%
Peripheral T-cell Lymphoma
16%
NVP-BGT226
16%
PET Imaging
16%
CD226
16%
Cancer Management
16%
Cluster of Differentiation 44 (CD44)
16%
Benzophenone Derivatives
16%
Glioma Stem Cells
16%
Structure-activity Analysis
16%
Isonicotinamide
16%
Regret
16%
Human Tissue Kallikrein
16%
Retinoic Acid Signaling
16%
Blastocystis
16%
Anticancer Agents
16%
Cellular Retinoic Acid Binding Protein 2
16%
Benzyl
16%
Laminin-2
16%
Acquired Hemophilia A
16%
Co-cultured Cells
16%
Preclinical Testing
16%
Netropsin
16%
DNA Minor Groove Binding Agent
16%
Quinoline-5,8-dione
16%
Salvia Miltiorrhiza Bunge
16%
Danshen
16%
Multidrug Sensitive
16%
2,2-diphenyl-1-picrylhydrazyl Radical
16%
Human Cell Lines
16%
Alternative Transcripts
16%
Fixed Tissue
16%
DNA Topoisomerase
16%
Antimutagenicity
16%
Adlay Hull
16%
Coix Lacryma-jobi L
16%
B-Raf
16%
Subfamily C
16%
Antimitotic
16%
Ether Derivatives
16%
Benzyl Ethers
16%
ATP-binding Cassette Transporter A1 (ABCA1)
16%
Orally Active
16%
Topoisomerase II Poison
16%
Biochemical Activity
16%
Ullmann
16%
Copper-mediated
16%
Heat Shock Protein 90 (Hsp90)
16%
MM-398
16%
PEP02
16%
Liposomal Irinotecan
16%
Metastatic Pancreatic Cancer
16%
Nucleus Translocation
16%
Potent Inhibitor
16%
Menadione
16%
Right Atrial Tumor Thrombus
16%
Intrahepatic Cholangiocarcinoma (iCCA)
16%
Undifferentiated Nasopharyngeal Carcinoma
16%
Non-polyadenylated RNAs
16%
Prometaphase
16%
2-hydroxy-1
16%
2-amino-1
16%
Indol
16%
Stomach mucosa
16%
Cryptomeria Japonica
16%
Ligand-based Pharmacophore
16%
Model Screening
16%
LDOC1
16%
BEX1
16%
Remnant Gastric Cancer
16%
Afferent Loop Syndrome
16%
Duodenal Drainage
16%
Ataxia Telangiectasia mutated
16%
Triheterocycles
16%
Severe Aplastic Anemia
16%
Adlay
16%
Immunology and Microbiology
Squamous Cell Carcinoma Cell
33%
Integrin
32%
Squamous Cell
22%
Lymph Node
21%
KB Cell Line
21%
Microtubule
19%
Cell Migration
19%
Acanthamoeba
18%
Cancer Cell
16%
Neck
16%
Caspase
16%
Acanthamoeba castellanii
16%
Protein Binding
16%
Malignant Progression
16%
Lymphangiogenesis
16%
Aminopeptidase
16%
Revertant
16%
Pseudomonas aeruginosa
16%
Protein Family
16%
Aplastic Anemia
16%
Allogeneic Bone Marrow Transplantation
16%
Laminin
16%
B Cell
16%
Glioma Stem Cell
16%
Antiangiogenic Activity
16%
Somatomedin
16%
Phagocytosis
16%
Coinfection
16%
CD44v Antigen
16%
Target Cell
16%
T Cell
16%
Western Blot
10%
Keratitis
9%
Colchicine
8%
Cell Cycle Arrest
8%
Cell Cycle Checkpoint
8%
Double-Strand DNA Break
8%
Nude Mouse
7%
Cell Damage
6%
Lifespan
6%
Cell Cycle M Phase
5%
Multidrug Resistance
5%
R-Factor
5%
Cytochrome
5%
Binding Site
5%
Mitochondrion
5%
Cancer Cell Line
5%
Cyclin B1
5%
Ileum
5%
Immunofluorescence
5%
Gastric Adenocarcinoma Cell Line
5%
Dephosphorylation
5%
Multidrug Resistance Associated Protein
5%
Upregulation
5%
Xenograft
5%
Bcl-2
5%